Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Scientists have devised an accurate and sensitive way to test blood to see if a pre-cancerous condition is escalating to outright cancer — potentially enabling treatment early in tumor development...
Immunovia’s "IMMray" technology uses an antibody microarray to detect the protein signature of pancreatic cancer in blood samples. The Swedish biotech firm Immunovia reached another milestone...